IE45454L - Cns-active compositions - Google Patents

Cns-active compositions

Info

Publication number
IE45454L
IE45454L IE771509A IE150977A IE45454L IE 45454 L IE45454 L IE 45454L IE 771509 A IE771509 A IE 771509A IE 150977 A IE150977 A IE 150977A IE 45454 L IE45454 L IE 45454L
Authority
IE
Ireland
Prior art keywords
compound
cns
active compositions
gabamimetic
formula
Prior art date
Application number
IE771509A
Other versions
IE45454B1 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7622045A external-priority patent/FR2358881A1/en
Priority claimed from FR7719390A external-priority patent/FR2453643A2/en
Application filed by Synthelabo filed Critical Synthelabo
Publication of IE45454L publication Critical patent/IE45454L/en
Publication of IE45454B1 publication Critical patent/IE45454B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PHARMACEUTICAL COMPOSITIONS HAVING AN ACTION ON THE CENTRAL NERVOUS SYSTEM The specification discloses pharmaceutical compositions, having an action on the central nervous system, containing a gabamimetic compound and a neuroleptic compound. The gabamimetic compound has the formula and the neuroleptic compound has the formula The compositions of the invention are medicaments which can be used in human therapy in the psychiatric field and, in particular, in the treatment of psychosis. [CA1077846A]
IE1509/77A 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system IE45454B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (en) 1976-07-20 1976-07-20 Neuroleptic compsn. contg. a gabamimetic potentiator - which is a benzylidene-amino-alkanoic acid deriv., for treating e.g. schizophrenia
FR7719390A FR2453643A2 (en) 1977-06-24 1977-06-24 PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CENTRAL NERVOUS SYSTEM

Publications (2)

Publication Number Publication Date
IE45454L true IE45454L (en) 1978-01-20
IE45454B1 IE45454B1 (en) 1982-08-25

Family

ID=26219550

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1509/77A IE45454B1 (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system

Country Status (11)

Country Link
JP (1) JPS5326327A (en)
AU (1) AU508753B2 (en)
CA (1) CA1077846A (en)
DE (1) DE2732614A1 (en)
GB (1) GB1556567A (en)
IE (1) IE45454B1 (en)
IL (1) IL52550A (en)
LU (1) LU77796A1 (en)
NL (1) NL7708055A (en)
NZ (1) NZ184666A (en)
SE (1) SE7708349L (en)

Also Published As

Publication number Publication date
CA1077846A (en) 1980-05-20
LU77796A1 (en) 1977-10-25
AU508753B2 (en) 1980-04-03
GB1556567A (en) 1979-11-28
DE2732614A1 (en) 1978-01-26
AU2715177A (en) 1979-01-25
IL52550A0 (en) 1977-10-31
SE7708349L (en) 1978-01-21
JPS5326327A (en) 1978-03-11
IE45454B1 (en) 1982-08-25
NZ184666A (en) 1980-04-28
NL7708055A (en) 1978-01-24
IL52550A (en) 1981-03-31

Similar Documents

Publication Publication Date Title
AU556039B2 (en) I.v. therapy or hyperalimentation catheter
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
IT7830192A0 (en) NITRO-SUBSTITUTED 1,4-DI-HYDRO-PYRIDINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS.
AU1575776A (en) The treatment of waste
GR3023638T3 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
IL49289A (en) N-substituted halo-2-pyrrolidinones, their preparation and their use as herbicides
IL59425A0 (en) N-substituted aziridine-2-carboxylic acid derivatives,processes for preparation thereof and pharmaceutical compositins containing the same
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU542902B2 (en) Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them
JPS5252112A (en) Spheroidizing treatment
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
DK0719276T3 (en) Estradiol esters with strong oral action as well as pharmaceutical preparations containing them
AU1312276A (en) Treatment for swine bysentery
IE45454L (en) Cns-active compositions
ES8403487A1 (en) N-(2-methoxyethyl)-noroxymorphone, its acid addition salts, medicines containing it and process for its preparation.
ZA838461B (en) Heterocyclyl compounds,processes for their manufacture,pharmaceutical preparations that contain these compounds,and the use of the latter
AU499509B2 (en) N-SUBSTITUTED c C AMINO METHYL-4HYDROXY 1, 3 BENZENE DIMETHANOI
IT8319024A0 (en) MEDICINAL COMPOSITION FOR THE TREATMENT OF CERTAIN NEUROVIROSES.
ES8504166A1 (en) 6,11-Dihydro-11,-oxo-dibenz(b,e)-oxepin derivatives, methods for their preparation, pharmaceutical compositions containing the same and their use as medicaments.
AU6527980A (en) N-substituted 2-amino-3,4-dihydro-pyridives
NZ180657A (en) 3-aminoalkyl-2-phenyl-bicyclo (2.2.2)-octane or-oct-2-ene derivatives,and pharmaceutical compositions
JPS5775969A (en) N-(1-aryl-2-pyrrolidinylmethyl)-2-methoxy-4- amino-5-methylsulfamoylbenzamide, manufacture and analgesic thereof as effective ingredient
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.
IT8721540A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRAPIDIL, THEIR PREPARATION PROCEDURE AND THEIR THERAPEUTIC USE.